I N recent months makers of weight-loss drugs have gone on a crash diet. In late July Novo Nordisk, the Danish firm that gave ...

From January, firms will be free to produce their own 'generic' versions-sending prices tumbling. Dozens of companies have ...

Novo Nordisk issued sales and profit warnings in July, and its share price was hammered, losing 20% or more in a single day.

Medicare Part D beneficiaries experienced a large increase in out-of-pocket spending for GLP-1s in 2025, according to ...

By Dennis Thompson HealthDay ReporterWEDNESDAY, Sept. 24, 2025 (HealthDay News) — A pill form of the blockbuster weight-loss ...

Gates Foundation and Novo Nordisk Novo Nordisk Foundation have extended the Acetate Consortium initiative with a $25.6M ...

The federal government is reluctant to back widespread funding for all overweight people who want drugs such as Ozempic and Wegovy.

( NewsNation) — New research has revealed that oral semaglutide can help with significant weight loss, with one in three ...

Because of its size, the drugmaker has an outsize effect on the country. Now, as it sheds jobs, forecasts for Denmark’s ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030.

Online pharmacies are using a loophole to continue selling cheap weight loss drugs that are modeled on Ozempic and Mounjaro, ...

With a weight-loss pill on the horizon and the FDA’s signal of a tougher stance on compounded knockoffs, Novo Nordisk might ...